Literature DB >> 17401620

Cycloplegic effect of 0.5% tropicamide and 0.5% phenylephrine mixed eye drops: objective assessment in Japanese schoolchildren with myopia.

Ichiro Hamasaki1, Satoshi Hasebe, Shuhei Kimura, Manabu Miyata, Hiroshi Ohtsuki.   

Abstract

PURPOSE: To evaluate the cycloplegic effect of mixed eye drops containing 0.5% tropicamide and 0.5% phenylephrine in myopic children, and to determine whether their efficacy was associated with their clinical characteristics.
METHODS: Eighty-one myopic children (age, mean +/- SD, 11.0 +/- 1.5 years; mean spherical equivalent refractive error, -4.27 +/- 1.41 D; range, -1.57 to -8.66 D) were recruited. One drop of Mydrin-P was administered to each eye twice, with an interval of 5 min between. Twenty-five minutes after the second drop, accommodative responses were measured with an open-view autorefractometer, while the subject was encouraged to accommodate by binocularly looking at a Maltese cross located at a distance of 33 cm. The difference between the refractive reading and that obtained with a Maltese cross at 500 cm was regarded as residual accommodation (RA). The repeatability of this measurement was also evaluated.
RESULTS: The mean RA was 0.21 +/- 0.29 D (range, -0.31 to 0.99 D). There was no association in RA between the right and left eyes, between RA and age, or between RA and sex, but RA was weakly correlated with refractive error (r = 0.274, P = 0.019). The intersubject difference found in RA can be explained mostly by the extent of repeatability (+/-0.71 D).
CONCLUSION: The insignificant magnitude of RA indicated that the mixed eye drop is an acceptable and useful cycloplegic agent in Japanese schoolchildren with a wide range of myopic refractive errors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401620     DOI: 10.1007/s10384-006-0400-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  29 in total

1.  Clinical evaluation of the Shin-Nippon SRW-5000 autorefractor in children.

Authors:  S W Chat; M H Edwards
Journal:  Ophthalmic Physiol Opt       Date:  2001-03       Impact factor: 3.117

2.  Tropicamide, a new cycloplegic mydriatic.

Authors:  B C GETTES
Journal:  Arch Ophthalmol       Date:  1961-05

3.  Tropicamide: comparative cycloplegic effects.

Authors:  B C GETTES; O BELMONT
Journal:  Arch Ophthalmol       Date:  1961-09

4.  Monovision slows juvenile myopia progression unilaterally.

Authors:  J R Phillips
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

5.  Refractive error at birth and its relation to gestational age.

Authors:  Sara Varughese; Raji Mathew Varghese; Nidhi Gupta; Rishikant Ojha; V Sreenivas; Jacob M Puliyel
Journal:  Curr Eye Res       Date:  2005-06       Impact factor: 2.424

6.  Time course of cycloplegia induced by a new phenylephrine-tropicamide combination drug.

Authors:  J V Lovasik; H Kergoat
Journal:  Optom Vis Sci       Date:  1990-05       Impact factor: 1.973

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Use of diagnostic pharmaceutical agents and incidence of adverse effects.

Authors:  M Applebaum; S D Jaanus
Journal:  Am J Optom Physiol Opt       Date:  1983-05

9.  Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria.

Authors:  Satoshi Hasebe; Fumitaka Nonaka; Chiaki Nakatsuka; Hiroshi Ohtsuki
Journal:  Jpn J Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 2.447

10.  Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide.

Authors:  J V Lovasik
Journal:  Am J Optom Physiol Opt       Date:  1986-10
View more
  8 in total

1.  Relative peripheral refraction in patients with horizontal strabismus.

Authors:  Kyoko Matsushita; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

2.  Axial length/corneal radius ratio: association with refractive state and role on myopia detection combined with visual acuity in Chinese schoolchildren.

Authors:  Xiangui He; Haidong Zou; Lina Lu; Rong Zhao; Huijuan Zhao; Qiangqiang Li; Jianfeng Zhu
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

3.  Changes in refractive characteristics in Japanese children with Down syndrome.

Authors:  Junna Horio; Hiroki Kaneko; Kei Takayama; Kinichi Tuzuki; Hiroko Kakihara; Miou Iwami; Yoshikatsu Kawase; Taichi Tsunekawa; Naoko Yamaguchi; Norie Nonobe; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2018-01-30       Impact factor: 2.447

4.  Screening for significant refractive error using a combination of distance visual acuity and near visual acuity.

Authors:  Peiyao Jin; Jianfeng Zhu; Haidong Zou; Lina Lu; Huijuan Zhao; Qiangqiang Li; Xiangui He
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

5.  Increase in esodeviation under cycloplegia with 0.5% tropicamide and 0.5% phenylephrine mixed eye drops in patients with hyperopia and esotropia.

Authors:  In Jeong Lyu; Kyung-Ah Park; Sei Yeul Oh
Journal:  BMC Ophthalmol       Date:  2017-12-12       Impact factor: 2.209

6.  Agreement and Repeatability of Noncycloplegic and Cycloplegic Wavefront-based Autorefraction in Children.

Authors:  Franziska G Rauscher; Heike Lange; Maryam Yahiaoui-Doktor; Helmut Tegetmeyer; Ina Sterker; Andreas Hinz; Siegfried Wahl; Peter Wiedemann; Arne Ohlendorf; Ralf Blendowske
Journal:  Optom Vis Sci       Date:  2019-11       Impact factor: 1.973

7.  Effects of Customized Progressive Addition Lenses vs. Single Vision Lenses on Myopia Progression in Children with Esophoria: A Randomized Clinical Trial.

Authors:  Xiaowei Zhu; Dongmei Wang; Naiyang Li; Feng Zhao
Journal:  J Ophthalmol       Date:  2022-02-27       Impact factor: 1.909

8.  Different patterns of myopia prevalence and progression between internal migrant and local resident school children in Shanghai, China: a 2-year cohort study.

Authors:  Yingyan Ma; Senlin Lin; Jianfeng Zhu; Xun Xu; Lina Lu; Rong Zhao; Huijuan Zhao; Qiangqiang Li; Zhiyuan Hou; Xiangui He; Haidong Zou
Journal:  BMC Ophthalmol       Date:  2018-02-23       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.